These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21970923)

  • 1. Algorithm for employing physical forces in metabolic bone diseases.
    Massari L
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):52-3. PubMed ID: 21970923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of physical forces in the management of bone and cartilage diseases and bone consolidation.
    Cadossi R
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):49-51. PubMed ID: 21970922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth hormone: effect on bone metabolism and bone density].
    Kann P; Piepkorn B; Schehler B; Andreas J; Lotz J; Bockisch A; Prellwitz W; Beyer J
    Med Klin (Munich); 1996 Feb; 91 Suppl 1():46-9. PubMed ID: 8839117
    [No Abstract]   [Full Text] [Related]  

  • 4. Case studies of kyphoplasty and vertebroplasty integrated by anti-osteoporotic therapy.
    Corradini C; Malagoli E; Verdoia C
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):45-6. PubMed ID: 21970920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total knee arthroplasty in elderly osteoporotic patients.
    Spinarelli A; Petrera M; Vicenti G; Pesce V; Patella V
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):78-80. PubMed ID: 21970933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone metabolism and disorders].
    Raue F; Ziegler R
    Internist (Berl); 1996 May; 37(5):539-49. PubMed ID: 9011558
    [No Abstract]   [Full Text] [Related]  

  • 7. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT.
    Sambrook PN; Silverman SL; Cauley JA; Recknor C; Olson M; Su G; Boonen S; Black D; Adachi JD;
    Bone; 2011 Jun; 48(6):1298-304. PubMed ID: 21421092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of a centralized regional referral center for metabolic bone diseases.
    Di Stefano M; D'Amelio P; Isaia G
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):31-2. PubMed ID: 18180606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fewer fractures after just 6 months. Fast help for tired bones].
    MMW Fortschr Med; 2002 Nov; 144(48):61. PubMed ID: 12532551
    [No Abstract]   [Full Text] [Related]  

  • 10. A prospective, randomized, double-blind study of the efficacy of postoperative continuous local anesthetic infusion at the iliac crest bone graft site after posterior spinal arthrodesis: a minimum of 4-year follow-up.
    Singh K; Phillips FM; Kuo E; Campbell M
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2790-6. PubMed ID: 18245999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.
    Turgeman G; Zilberman Y; Zhou S; Kelly P; Moutsatsos IK; Kharode YP; Borella LE; Bex FJ; Komm BS; Bodine PV; Gazit D
    J Cell Biochem; 2002; 86(3):461-74. PubMed ID: 12210753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
    López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
    Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].
    Torregrosa JV; Cannata Andia J; Bover J; Caravaca F; Lorenzo V; Martín de Francisco AL; Martín-Malo A; Martínez I; González Parra E; Fernández Giráldez E; Rodríguez Portillo M;
    Nefrologia; 2008; 28 Suppl 1():1-22. PubMed ID: 18338978
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteopenia and cancer in children and adolescents: the fragility of success.
    Sala A; Barr RD
    Cancer; 2007 Apr; 109(7):1420-31. PubMed ID: 17326055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone health as a primary target in the pediatric age.
    Caradonna P; Rigante D
    Eur Rev Med Pharmacol Sci; 2009; 13(2):117-28. PubMed ID: 19499847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.
    Silverman SL; Christiansen C; Genant HK; Vukicevic S; Zanchetta JR; de Villiers TJ; Constantine GD; Chines AA
    J Bone Miner Res; 2008 Dec; 23(12):1923-34. PubMed ID: 18665787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone physiology and therapeutics in chronic critical illness.
    Via MA; Gallagher EJ; Mechanick JI
    Ann N Y Acad Sci; 2010 Nov; 1211():85-94. PubMed ID: 21062297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical biophysics: the promotion of skeletal repair by physical forces.
    Aaron RK; Ciombor DM; Wang S; Simon B
    Ann N Y Acad Sci; 2006 Apr; 1068():513-31. PubMed ID: 16831948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studies.
    Pastores GM; Elstein D; Hrebícek M; Zimran A
    Clin Ther; 2007 Aug; 29(8):1645-54. PubMed ID: 17919546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.